Alpinetin activates the δ receptor instead of the κ and µ receptor pathways to protect against rat myocardial cell apoptosis

Suo,Chuantao; Sun,Libo; Yang,Shuang

doi:10.3892/etm.2013.1359

Alpinetin activates the δ receptor instead of the κ and µ receptor pathways to protect against rat myocardial cell apoptosis

Authors:
- Chuantao Suo
- Libo Sun
- Shuang Yang
View Affiliations

Affiliations: Department of Cardiology, Daqing General Hospital Group Oilfield General Hospital, Daqing, Heilongjiang 163000, P.R. China, Department of Gastrointestinal Surgery, China‑Japan Union Hospital, Jilin University, Changchun, Jilin 130021, P.R. China, Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China
Published online on: October 23, 2013 https://doi.org/10.3892/etm.2013.1359
Pages: 109-116

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Alpinetin is a natural flavonoid that protects cells against fatal injury in ischemia‑reperfusion. δ receptor activation protects myocardial cells from trauma; however, the mechanism is unknown. The aim of this study was to explore the function of alpinetin in δ receptor‑mediated myocardial apoptosis. The myocardial cells of newly born rats were cultivated and myocardial apoptosis was induced by serum deprivation. The MTT method was used to evaluate cell viability and Annexin V‑fluorescein isothiocyanate (FITC)/propidium iodide (PI) staining was used to analyze apoptosis. The expression levels of opioid receptor mRNA and protein were tested using reverse transcription‑polymerase reaction (RT‑PCR) and western blot assays. In addition, an opioid receptor antagonist, as well as protein kinase C (PKC) and extracellular signal‑regulated kinase (ERK) inhibitors, were used to determine the inferred signaling pathway. The results showed that that alpinetin reduced the myocardial apoptosis induced by serum deprivation in a concentration‑dependent manner. However, the protection conferred to the myocardial cells by alpinetin was blocked by the δ opioid receptor antagonist naltrindole, as well as by PKC and ERK inhibitors (GF109203X and U0126, respectively). In addition, it was shown that alpinetin was able to maintain the stability of the mitochondrial membrane potential, lower the level of intracytoplasmic cytochrome c and reduce Bax displacement from the cytoplasm to the mitochondria. It was concluded that alpinetin was able to activate δ receptors to induce the endogenous protection of myocardial cells via the PKC/ERK signaling pathway.

View Figures

View References

1	Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:239–257. 1972. View Article : Google Scholar : PubMed/NCBI
2	Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456–1462. 1995. View Article : Google Scholar : PubMed/NCBI
3	Gottlieb RA, Burleson KO, Kloner RA, Babior BM and Engler RL: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1621–1628. 1994. View Article : Google Scholar : PubMed/NCBI
4	Wang ZT, Lau CW, Chan FL, Yao X, Chen ZY, He ZD and Huang Y: Vasorelaxant effects of cardamonin and alpinetin from Alpinia henryi K. Schum. J Cardiovasc Pharmacol. 37:596–606. 2001. View Article : Google Scholar : PubMed/NCBI
5	He W, Li Y, Xue C, Hu Z, Chen X and Sheng F: Effect of Chinese medicine alpinetin on the structure of human serum albumin. Bioorg Med Chem. 13:1837–1845. 2005. View Article : Google Scholar : PubMed/NCBI
6	He W, Li Y, Tang J, Luan F, Jin J and Hu Z: Comparison of the characterization on binding of alpinetin and cardamonin to lysozyme by spectroscopic methods. Int J Biol Macromol. 39:165–173. 2006. View Article : Google Scholar : PubMed/NCBI
7	Tang J, Li N, Dai H and Wang K: Chemical constituents from seeds of Alpinia katsumadai, inhibition on NF-kappaB activation and anti-tumor effect. Zhongguo Zhong Yao Za Zhi. 35:1710–1714. 2010.(In Chinese).
8	Feng Y, He X, Yang Y, Chao D, Lazarus LH and Xia Y: Current research on opioid receptor function. Curr Drug Targets. 13:230–246. 2012. View Article : Google Scholar : PubMed/NCBI
9	Wang D, Wang H, Wu G, Yang Y, Yang J, Liu C and Wong TM: Protein kinase C mediates the effects of delta-opioid receptor stimulation on survival and apoptosis in neonatal cardiomyocytes cultured in serum-deprived condition. Pharmazie. 64:466–471. 2009.
10	Maslov LN, Barzakh EI, Krylatov AV, Chernysheva GA, Krieg T, Solenkova NV, Lishmanov AY, Cybulnikov SY and Zhang Y: Opioid peptide deltorphin II simulates the cardioprotective effect of ischemic preconditioning: role of δ₂-opioid receptors, protein kinase C, and K(ATP) channels. Bull Exp Biol Med. 149:591–593. 2010.PubMed/NCBI
11	Wang S, Duan Y, Su D, Li W, Tan J, Yang D, Wang W, Zhao Z and Wang X: Delta opioid peptide (D-Ala2, D-Leu5) enkephalin (DADLE) triggers postconditioning against transient forebrain ischemia. Eur J Pharmacol. 658:140–144. 2011. View Article : Google Scholar
12	Aitchison KA, Baxter GF, Awan MM, Smith RM, Yellon DM and Opie LH: Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning. Basic Res Cardiol. 95:1–11. 2000. View Article : Google Scholar
13	Schultz JJ, Hsu AK and Gross GJ: Ischemic preconditioning and morphine-induced cardioprotection involve the delta (delta)-opioid receptor in the intact rat heart. J Mol Cell Cardiol. 29:2187–2195. 1997. View Article : Google Scholar
14	Genade S, Moolman JA and Lochner A: Opioid receptor stimulation acts as mediator of protection in ischaemic preconditioning. Cardiovasc J S Afr. 12:8–16. 2001.PubMed/NCBI
15	Miki T, Cohen MV and Downey JM: Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Mol Cell Biochem. 186:3–12. 1998. View Article : Google Scholar : PubMed/NCBI
16	Lopez-Ilasaca M, Crespo P, Pellici PG, Gutkind JS and Wetzker R: Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma. Science. 275:394–397. 1997. View Article : Google Scholar : PubMed/NCBI
17	Polakiewicz RD, Schieferl SM, Gingras AC, Sonenberg N and Comb MJ: mu-Opioid receptor activates signaling pathways implicated in cell survival and translational control. J Biol Chem. 273:23534–23541. 1998. View Article : Google Scholar : PubMed/NCBI
18	Zhang Z, Xin SM, Wu GX, Zhang WB, Ma L and Pei G: Endogenous delta-opioid and ORL1 receptors couple to phosphorylation and activation of p38 MAPK in NG108-15 cells and this is regulated by protein kinase A and protein kinase C. J Neurochem. 73:1502–1509. 1999. View Article : Google Scholar : PubMed/NCBI
19	Wilson MA, Burt AR, Milligan G and Anderson NG: Mitogenic signalling by delta opioid receptors expressed in rat-1 fibroblasts involves activation of the p70s6k/p85s6k S6 kinase. Biochem J. 325:217–222. 1997.PubMed/NCBI
20	Fukuda K, Kato S, Morikawa H, Shoda T and Mori K: Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J Neurochem. 67:1309–1316. 1996. View Article : Google Scholar
21	Wang S, Huang X, Li Y, Lao H, Zhang Y, Dong H, Xu W, Li JL and Li M: RN181 suppresses hepatocellular carcinoma growth by inhibition of the ERK/MAPK pathway. Hepatology. 53:1932–1942. 2011. View Article : Google Scholar : PubMed/NCBI
22	Hayashi T, Tsao LI and Su TP: Antiapoptotic and cytotoxic properties of delta opioid peptide [D-Ala², D-Leu⁵]enkephalin in PC12 cells. Synapse. 43:86–94. 2002.PubMed/NCBI
23	Bilecki W, Zapart G, Ligeza A, Wawrzczak-Bargiela A, Urbański MJ and Przewłocki R: Regulation of the extracellular signal-regulated kinases following acute and chronic opioid treatment. Cell Mol Life Sci. 62:2369–2375. 2005. View Article : Google Scholar : PubMed/NCBI
24	Tang B, Zhao L, Liang R, Zhang Y and Wang L: Magnetic nanoparticles: an improved method for mitochondrial isolation. Mol Med Rep. 5:1271–1276. 2012.PubMed/NCBI
25	Akhlaghi M and Bandy B: Preconditioning and acute effects of flavonoids in protecting cardiomyocytes from oxidative cell death. Oxid Med Cell Longev. 2012:7823212012.PubMed/NCBI
26	Sato Y, Itagaki S, Oikawa S, Ogura J, Kobayashi M, Hirano T, Sugawara M and Iseki K: Protective effect of soy isoflavone genistein on ischemia-reperfusion in the rat small intestine. Biol Pharm Bull. 34:1448–1454. 2011. View Article : Google Scholar : PubMed/NCBI
27	Chan E, Liu XX, Guo DJ, Kwan YW, Leung GP, Lee SM and Chan SW: Extract of Scutellaria baicalensis Georgi root exerts protection against myocardial ischemia-reperfusion injury in rats. Am J Chin Med. 39:693–704. 2011.
28	Fisher SA, Langille BL and Srivastava D: Apoptosis during cardiovascular development. Circ Res. 87:856–864. 2000. View Article : Google Scholar : PubMed/NCBI
29	Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F and Hiroe M: Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 75:426–433. 1994. View Article : Google Scholar : PubMed/NCBI
30	Goyeneche AA, Harmon JM and Telleria CM: Cell death induced by serum deprivation in luteal cells involves the intrinsic pathway of apoptosis. Reproduction. 131:103–111. 2006. View Article : Google Scholar : PubMed/NCBI
31	Zimlichman R, Gefel D, Eliahou H, Matas Z, Rosen B, Gass S, Ela C, Eilam Y, Vogel Z and Barg J: Expression of opioid receptors during heart ontogeny in normotensive and hypertensive rats. Circulation. 93:1020–1025. 1996. View Article : Google Scholar : PubMed/NCBI
32	Su TP: Delta opioid peptide [D-Ala²,D-Leu⁵]enkephalin promotes cell survival. J Biomed Sci. 7:195–199. 2000.
33	Kim H, Lee SW, Park JS, Min JH and Kim HK: Genomic analysis of [d-Ala², d-Leu⁵] enkephalin preconditioning in cortical neuron and glial cell injury after oxygen deprivation. Brain Res. 1447:91–105. 2012.
34	Xin W, Yang X, Rich TC, Krieg T, Barrington R, Cohen MV and Downey JM: All preconditioning-related G protein-coupled receptors can be demonstrated in the rabbit cardiomyocyte. J Cardiovasc Pharmacol Ther. 17:190–198. 2012. View Article : Google Scholar : PubMed/NCBI
35	Zhao M, Wang HX, Yang J, Su YH, Su RJ and Wong TM: delta-Opioid receptor stimulation enhances the growth of neonatal rat ventricular myocytes via the extracellular signal-regulated kinase pathway. Clin Exp Pharmacol Physiol. 35:97–102. 2008. View Article : Google Scholar : PubMed/NCBI
36	Olianas MC, Dedoni S, Olianas A and Onali P: δ-Opioid receptors stimulate the metabolic sensor AMP-activated protein kinase through coincident signaling with G(q/11)-coupled receptors. Mol Pharmacol. 81:154–165. 2012.
37	Pateliya BB, Singh N and Jaggi AS: Possible role of opioids and KATP channels in neuroprotective effect of postconditioning in mice. Biol Pharm Bull. 31:1755–1760. 2008. View Article : Google Scholar : PubMed/NCBI
38	Tang B, Zhang Y, Liang R, Yuan P, Du J, Wang H and Wang L: Activation of the δ-opioid receptor inhibits serum deprivation-induced apoptosis of human liver cells via the activation of PKC and the mitochondrial pathway. Int J Mol Med. 28:1077–1085. 2011.
39	Saberi B, Shinohara M, Ybanez MD, Hanawa N, Gaarde WA, Kaplowitz N and Han D: Regulation of H₂O₂-induced necrosis by PKC and AMP-activated kinase signaling in primary cultured hepatocytes. Am J Physiol Cell Physiol. 295:C50–C63. 2008.
40	Molè D, Gentilin E, Gagliano T, Tagliati F, Bondanelli M, Pelizzo MR, Rossi M, Filieri C, Pansini G, degli Uberti EC and Zatelli MC: Protein kinase C: a putative new target for the control of human medullary thyroid carcinoma cell proliferation in vitro. Endocrinology. 153:2088–2098. 2012.PubMed/NCBI
41	Wickley PJ, Ding X, Murray PA and Damron DS: Propofol-induced activation of protein kinase C isoforms in adult rat ventricular myocytes. Anesthesiology. 104:970–977. 2006. View Article : Google Scholar : PubMed/NCBI
42	Ali AS, Ali S, El-Rayes BF, Philip PA and Sarkar FH: Exploitation of protein kinase C: a useful target for cancer therapy. Cancer Treat Rev. 35:1–8. 2009. View Article : Google Scholar : PubMed/NCBI
43	Kao HH, Wu CJ, Won SJ, Shin JW, Liu HS and Su CL: Kinase gene expression and subcellular protein expression pattern of protein kinase C isoforms in curcumin-treated human hepatocellular carcinoma Hep 3B cells. Plant Foods Hum Nutr. 66:136–142. 2011. View Article : Google Scholar
44	Tsao LI and Su TP: Hibernation-induction peptide and cell death: (D-Ala²,D-Leu⁵)enkephalin blocks Bax-related apoptotic processes. Eur J Pharmacol. 428:149–151. 2001. View Article : Google Scholar : PubMed/NCBI